Antiviral and Monoclonal Antibody Combination Therapy in Haematological Patients in the Omicron Era

被引：0
|
作者：
Vita, Serena [1 ]
Giombini, Emanuela [1 ]
De Marco, Patrizia [1 ]
Rueca, Martina [1 ]
Gruber, Cesare Ernesto Maria [1 ]
Beccacece, Alessia [1 ]
Scorzolini, Laura [1 ]
Mazzotta, Valentina [1 ]
Pinnetti, Carmen [1 ]
Caputi, Priscilla [1 ]
Focosi, Daniele [2 ]
Girardi, Enrico [1 ]
Antinori, Andrea [1 ]
Maggi, Fabrizio [1 ]
D'Abramo, Alessandra [1 ]
Nicastri, Emanuele [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Via Portuense 292, I-00149 Rome, Italy
[2] Pisa Univ Hosp, North Western Tuscany Blood Bank, Pisa, Italy
来源：
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2024年 / 16卷 / 01期
关键词：
Immunocompromised; SARS-CoV-2; infection; Monoclonal antibodies; Antivirals; Persistent infection; Viral evolution; IMMUNOCOMPROMISED PATIENTS; COVID-19; EMERGENCE; MUTATIONS; OUTCOMES;
D O I：
10.4084/MJHID.2024.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Monoclonal Antibody Therapy of Haematological Malignancies
    Claire Dearden
    BioDrugs, 2002, 16 : 283 - 301
  • [2] Monoclonal Antibody Therapy in Haematological Malignancies
    Chamuleau, Martine E. D.
    van de Loosdrecht, Arjan A.
    Huijgens, Peter C.
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03): : 148 - 159
  • [3] Monoclonal antibody therapy of haematological malignancies
    Dearden, C
    BIODRUGS, 2002, 16 (04) : 283 - 301
  • [4] Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
    Ren, Zuning
    Shen, Chenguang
    Peng, Jie
    VIRUSES-BASEL, 2023, 15 (06):
  • [5] Infection Risk in Patients with Multiple Myeloma during the Era of Monoclonal Antibody Therapy
    Hoffman, Stephanie
    Kandarpa, Malathi
    Ye, Jing Christine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S256 - S257
  • [6] Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy
    Kiasari, Bahman Abedi
    Abbasi, Arash
    Darestani, Nadia Ghasemi
    Adabi, Nasim
    Moradian, Arsalan
    Yazdani, Yalda
    Hosseini, Golsa Sadat
    Gholami, Nasrin
    Janati, Sheida
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [7] Monoclonal Antibody and Antiviral Therapy for Mild-to-Moderate COVID-19 in Pediatric Patients
    Vora, Surabhi B. B.
    Englund, Janet A. A.
    Trehan, Indi
    Waghmare, Alpana
    Kong, Ada
    Adler, Amanda
    Zerr, Danielle M. M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (01) : 32 - 34
  • [8] Antiviral monoclonal antibody therapies
    Florez, Catalina
    Haslwanter, Denise
    Jangra, Rohit K.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [9] Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study
    Calderon-Parra, Jorge
    Gutierrez-Villanueva, Andrea
    Ronda-Roca, Gerard
    Jimenez, Maria Luisa Martin
    de la Torre, Helena
    Rodenas-Baquero, Maria
    Paniura-Pinedo, Maria
    Lozano-Llano, Carla
    Pintos-Pascual, Ilduara
    Fernandez-Cruz, Ana
    Ramos-Martinez, Antonio
    Munez-Rubio, Elena
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (03)
  • [10] Combination Antiviral Therapy in Patients With Bell Palsy
    de Ru, J. Alexander
    Bayoumy, Ahmed Bayoumy
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (10) : 977 - 978
12345